{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T08:45:09Z","timestamp":1775983509066,"version":"3.50.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,12]]},"DOI":"10.7759\/cureus.106873","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T08:01:11Z","timestamp":1775980871000},"source":"Crossref","is-referenced-by-count":0,"title":["Very Late-Onset Post-transplant Lymphoproliferative Disorder Presenting as Small Bowel Obstruction After Initial Remission in a Living-Donor Kidney Transplant Recipient"],"prefix":"10.7759","author":[{"given":"Yu","family":"Shimada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiji","family":"Takamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeaki","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kawahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-ichi","family":"Teranishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2005.03.015","article-title":"Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation","volume":"56","author":"Taylor AL","year":"2005","unstructured":"Taylor AL, Marcus R, Bradley JA. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol. 2005, 56:155-67. 10.1016\/j.critrevonc.2005.03.015","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000004919","article-title":"Mechanistic understanding of EBV+ lymphoproliferative disease development after transplantation","volume":"108","author":"Furlano PL","year":"2024","unstructured":"Furlano PL, B\u00f6hmig GA, Puchhammer-St\u00f6ckl E, Vietzen H. Mechanistic understanding of EBV+ lymphoproliferative disease development after transplantation. Transplantation. 2024, 108:1867-81. 10.1097\/TP.0000000000004919","journal-title":"Transplantation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2016.130","article-title":"EBV-negative monomorphic B-cell post-transplant lymphoproliferative disorders are pathologically distinct from EBV-positive cases and frequently contain TP53 mutations","volume":"29","author":"Courville EL","year":"2016","unstructured":"Courville EL, Yohe S, Chou D, et al.. EBV-negative monomorphic B-cell post-transplant lymphoproliferative disorders are pathologically distinct from EBV-positive cases and frequently contain TP53 mutations. Mod Pathol. 2016, 29:1200-11. 10.1038\/modpathol.2016.130","journal-title":"Mod Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1702693","article-title":"Post-transplantation lymphoproliferative disorders in adults","volume":"378","author":"Dierickx D","year":"2018","unstructured":"Dierickx D, Habermann TM. Post-transplantation lymphoproliferative disorders in adults. N Engl J Med. 2018, 378:549-62. 10.1056\/NEJMra1702693","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13558","article-title":"EBV-positive and EBV-negative posttransplant diffuse large B-cell lymphomas have distinct genomic and transcriptomic features","volume":"16","author":"Ferreiro JF","year":"2016","unstructured":"Ferreiro JF, Morscio J, Dierickx D, et al.. EBV-positive and EBV-negative posttransplant diffuse large B-cell lymphomas have distinct genomic and transcriptomic features. Am J Transplant. 2016, 16:414-25. 10.1111\/ajt.13558","journal-title":"Am J Transplant"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12858","article-title":"A comprehensive analysis of the cellular and EBV-specific microRNAome in primary CNS PTLD identifies different patterns among EBV-associated tumors","volume":"14","author":"Fink SE","year":"2014","unstructured":"Fink SE, Gandhi MK, Nourse JP, et al.. A comprehensive analysis of the cellular and EBV-specific microRNAome in primary CNS PTLD identifies different patterns among EBV-associated tumors. Am J Transplant. 2014, 14:2577-87. 10.1111\/ajt.12858","journal-title":"Am J Transplant"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14633","article-title":"Mutational landscape of B-cell post-transplant lymphoproliferative disorders","volume":"178","author":"Menter T","year":"2017","unstructured":"Menter T, Juskevicius D, Alikian M, Steiger J, Dirnhofer S, Tzankov A, Naresh KN. Mutational landscape of B-cell post-transplant lymphoproliferative disorders. Br J Haematol. 2017, 178:48-56. 10.1111\/bjh.14633","journal-title":"Br J Haematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70300-X","article-title":"Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial","volume":"13","author":"Trappe R","year":"2012","unstructured":"Trappe R, Oertel S, Leblond V, et al.. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial. Lancet Oncol. 2012, 13:196-206. 10.1016\/S1470-2045(11)70300-X","journal-title":"Lancet Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000648","article-title":"Management and outcomes of diffuse large B-cell lymphoma post-transplant lymphoproliferative disorder in the era of PET and rituximab: a multicenter study from the Australasian Lymphoma Alliance","volume":"5","author":"Boyle S","year":"2021","unstructured":"Boyle S, Tobin JW, Perram J, et al.. Management and outcomes of diffuse large B-cell lymphoma post-transplant lymphoproliferative disorder in the era of PET and rituximab: a multicenter study from the Australasian Lymphoma Alliance. Hemasphere. 2021, 5:e648. 10.1097\/HS9.0000000000000648","journal-title":"Hemasphere"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/471707-very-late-onset-post-transplant-lymphoproliferative-disorder-presenting-as-small-bowel-obstruction-after-initial-remission-in-a-living-donor-kidney-transplant-recipient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T08:01:12Z","timestamp":1775980872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/471707-very-late-onset-post-transplant-lymphoproliferative-disorder-presenting-as-small-bowel-obstruction-after-initial-remission-in-a-living-donor-kidney-transplant-recipient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,12]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.106873","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,12]]}}}